Intracellular Targeting Mechanisms by Antimicrobial Peptides

ABSTRACT Antimicrobial peptides (AMPs) are expressed in various living organisms as first-line host defenses against potential harmful encounters in their surroundings. AMPs are short polycationic peptides exhibiting various antimicrobial activities. The principal antibacterial activity is attributed to the membrane-lytic mechanism which directly interferes with the integrity of the bacterial cell membrane and cell wall. In addition, a number of AMPs form a transmembrane channel in the membrane by self-aggregation or polymerization, leading to cytoplasm leakage and cell death. However, an increasing body of evidence has demonstrated that AMPs are able to exert intracellular inhibitory activities as the primary or supportive mechanisms to achieve efficient killing. In this review, we focus on the major intracellular targeting activities reported in AMPs, which include nucleic acids and protein biosynthesis and protein-folding, protease, cell division, cell wall biosynthesis, and lipopolysaccharide inhibition. These multifunctional AMPs could serve as the potential lead peptides for the future development of novel antibacterial agents with improved therapeutic profiles.

[1]  P. Tempst,et al.  Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. , 1994, Biochemical and biophysical research communications.

[2]  T. Sorsa,et al.  The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases. , 1990, Archives of oral biology.

[3]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[4]  Lin Yang Neutron off-plane scattering of aligned membranes , 1998 .

[5]  S H White,et al.  Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. , 1997, Biophysical journal.

[6]  Wayne L. Smith,et al.  Purification, primary structures, and antibacterial activities of β-defensins, a new family of antimicrobial peptides from bovine neutrophils. , 1996, The Journal of Biological Chemistry.

[7]  R. Hancock,et al.  Alternative mechanisms of action of cationic antimicrobial peptides on bacteria , 2007, Expert review of anti-infective therapy.

[8]  D. Andersson,et al.  Mechanism and Fitness Costs of PR-39 Resistance in Salmonella enterica Serovar Typhimurium LT2 , 2008, Antimicrobial Agents and Chemotherapy.

[9]  J. Grogan,et al.  Salivary histatin 5 is a potent competitive inhibitor of the cysteine proteinase clostripain , 2001, FEBS letters.

[10]  R. Nagaraj,et al.  Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13‐residue peptide indolicidin , 1996, FEBS letters.

[11]  C. Griesinger,et al.  Constitution and solution conformation of the antibiotic mersacidin determined by NMR and molecular dynamics. , 1997, European journal of biochemistry.

[12]  V. Saba,et al.  Neutralization of Endotoxin In Vitro and In Vivo by BAC7(1-35), a Proline-Rich Antibacterial Peptide , 2003, Shock.

[13]  Ayyalusamy Ramamoorthy,et al.  LL-37, the only human member of the cathelicidin family of antimicrobial peptides. , 2006, Biochimica et biophysica acta.

[14]  J. Helterbrand,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis , 2003 .

[15]  C. Esmon Regulation of blood coagulation. , 2000, Biochimica et biophysica acta.

[16]  Y. Shai,et al.  Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.

[17]  R. Farías,et al.  The peptide antibiotic microcin 25 is imported through the TonB pathway and the SbmA protein , 1995, Journal of bacteriology.

[18]  E. Breukink,et al.  Lipid II as a target for antibiotics , 2006, Nature Reviews Drug Discovery.

[19]  V. Iacono,et al.  Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans , 1984, Infection and immunity.

[20]  J. Wiesner,et al.  Insect antimicrobial peptides show potentiating functional interactions against Gram-negative bacteria , 2015, Proceedings of the Royal Society B: Biological Sciences.

[21]  R. Lehrer,et al.  Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils , 1993, Infection and immunity.

[22]  K. Entian,et al.  Two Different Lantibiotic-Like Peptides Originate from the Ericin Gene Cluster of Bacillus subtilis A1/3 , 2002, Journal of bacteriology.

[23]  A. Pugsley,et al.  Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. , 1986, Journal of general microbiology.

[24]  T. Meinnel,et al.  The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis. , 2014, Chemistry & biology.

[25]  B. Ho,et al.  Interpretation of biological activity data of bacterial endotoxins by simple molecular models of mechanism of action. , 2000, European journal of biochemistry.

[26]  M. Phansalkar,et al.  Mersacidin, a new antibiotic from Bacillus. Fermentation, isolation, purification and chemical characterization. , 1992, The Journal of antibiotics.

[27]  R. Hoffmann,et al.  Rational Design of Oncocin Derivatives with Superior Protease Stabilities and Antibacterial Activities Based on the High‐Resolution Structure of the Oncocin‐DnaK Complex , 2011, Chembiochem : a European journal of chemical biology.

[28]  Wei-Ting Huang,et al.  Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA , 2005, Nucleic acids research.

[29]  S. Sekaran,et al.  In vivo efficacy and molecular docking of designed peptide that exhibits potent antipneumococcal activity and synergises in combination with penicillin , 2015, Scientific Reports.

[30]  C. Gaggero,et al.  Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli , 1990, Journal of bacteriology.

[31]  Alan J. Waring,et al.  Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.

[32]  R. Nagaraj,et al.  Indolicidin, a 13-residue basic antimicrobial peptide rich in tryptophan and proline, interacts with Ca(2+)-calmodulin. , 2003, Biochemical and biophysical research communications.

[33]  C. Raetz,et al.  Lipid A modification systems in gram-negative bacteria. , 2007, Annual review of biochemistry.

[34]  R. Hancock,et al.  Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification , 1994, Antimicrobial Agents and Chemotherapy.

[35]  T. Miyata,et al.  Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. , 1988, The Journal of biological chemistry.

[36]  W. Foss,et al.  Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. , 1998, The Journal of clinical investigation.

[37]  Ashok Kumar,et al.  Tumor Necrosis Factor-α Induces Functionally Active Hyaluronan-adhesive CD44 by Activating Sialidase through p38 Mitogen-activated Protein Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells* , 2003, Journal of Biological Chemistry.

[38]  S. Lovas,et al.  The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.

[39]  Y. Pommier,et al.  Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites , 2006, Nucleic acids research.

[40]  H. Vogel,et al.  The expanding scope of antimicrobial peptide structures and their modes of action. , 2011, Trends in biotechnology.

[41]  J. Potempa,et al.  Salivary Histatin 5 Is an Inhibitor of Both Host and Bacterial Enzymes Implicated in Periodontal Disease , 2001, Infection and Immunity.

[42]  C. Walsh,et al.  Thiazole and oxazole peptides: biosynthesis and molecular machinery. , 1999, Natural product reports.

[43]  W. Vollmer,et al.  Morphogenesis of Escherichia coli. , 2001, Current opinion in microbiology.

[44]  R. Hancock Peptide antibiotics , 1997, The Lancet.

[45]  O. Kuipers,et al.  An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II , 2006, Science.

[46]  Michelle D. Wang,et al.  Molecular mechanism of transcription inhibition by peptide antibiotic Microcin J25. , 2004, Molecular cell.

[47]  S. Lovas,et al.  Interaction between heat shock proteins and antimicrobial peptides. , 2000, Biochemistry.

[48]  Yi-Wen Chen,et al.  Systematic Analysis of Intracellular-targeting Antimicrobial Peptides, Bactenecin 7, Hybrid of Pleurocidin and Dermaseptin, Proline–Arginine-rich Peptide, and Lactoferricin B, by Using Escherichia coli Proteome Microarrays* , 2016, Molecular & Cellular Proteomics.

[49]  P. Tempst,et al.  Apidaecins: antibacterial peptides from honeybees. , 1989, The EMBO journal.

[50]  L. Becucci,et al.  Dermcidin, an anionic antimicrobial peptide: influence of lipid charge, pH and Zn2+ on its interaction with a biomimetic membrane. , 2014, Soft matter.

[51]  M. Selsted,et al.  Synthesis and characterization of indolicidin, a tryptophan-rich antimicrobial peptide from bovine neutrophils * , 2009 .

[52]  H. Sahl,et al.  Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase , 1987, Journal of bacteriology.

[53]  S. Levitz,et al.  Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. , 1988, The Journal of biological chemistry.

[54]  P. Yu,et al.  Mechanisms of action of ostrich β‐defensins against Escherichia coli , 2007 .

[55]  B. Schonwetter,et al.  Epithelial antibiotics induced at sites of inflammation , 1995, Science.

[56]  C. Subbalakshmi,et al.  Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.

[57]  R. Hancock,et al.  Cationic peptides: effectors in innate immunity and novel antimicrobials. , 2001, The Lancet. Infectious diseases.

[58]  A. Mor,et al.  Peptides as weapons against microorganisms in the chemical defense system of vertebrates. , 1995, Annual review of microbiology.

[59]  Y. Tu,et al.  Identification of Lactoferricin B Intracellular Targets Using an Escherichia coli Proteome Chip , 2011, PloS one.

[60]  R. Kaptein,et al.  The nisin–lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics , 2004, Nature Structural &Molecular Biology.

[61]  G. Wider,et al.  Copsin, a Novel Peptide-based Fungal Antibiotic Interfering with the Peptidoglycan Synthesis* , 2014, The Journal of Biological Chemistry.

[62]  M. Benincasa,et al.  Dual mode of action of Bac7, a proline-rich antibacterial peptide. , 2006, Biochimica et biophysica acta.

[63]  Ellis Rj The molecular chaperone concept. , 1990 .

[64]  S. Gordon,et al.  The potential for Toll‐like receptors to collaborate with other innate immune receptors , 2004, Immunology.

[65]  S. Sekaran,et al.  Transcriptome analysis of Streptococcus pneumoniae treated with the designed antimicrobial peptides, DM3 , 2016, Scientific Reports.

[66]  Chong Li,et al.  Functional interaction of human neutrophil peptide‐1 with the cell wall precursor lipid II , 2010, FEBS letters.

[67]  R. Hancock,et al.  Mode of Action of the Antimicrobial Peptide Indolicidin* , 1996, The Journal of Biological Chemistry.

[68]  Patchen Dellinger,et al.  Practice guidelines for the diagnosis and management of skin and soft-tissue infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  R. Hancock,et al.  Antiendotoxin activity of cationic peptide antimicrobial agents , 1996, Infection and immunity.

[70]  Elizabeth M. Nolan,et al.  Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5. , 2015, Biochemistry.

[71]  A. L. Koch Bacterial Wall as Target for Attack , 2003, Clinical Microbiology Reviews.

[72]  A. Bottrill,et al.  The action of the bacterial toxin, microcin B17, on DNA gyrase. , 2007, Biochimie.

[73]  O. Franco,et al.  Deciphering the Magainin Resistance Process of Escherichia coli Strains in Light of the Cytosolic Proteome , 2012, Antimicrobial Agents and Chemotherapy.

[74]  R. Lanot,et al.  Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus. , 1994, The Biochemical journal.

[75]  M. Selsted,et al.  Anti‐HIV‐1 activity of indolicidin, an antimicrobial peptide from neutrophils , 1998, Journal of leukocyte biology.

[76]  Takanori Nakamura,et al.  Tachyplesin, a Class of Antimicrobial Peptide from the Hemocytes of the Horseshoe Crab (Tach ypleus tridentatus) , 1988 .

[77]  Y. Shai,et al.  Mode of action of linear amphipathic alpha-helical antimicrobial peptides. , 1998, Biopolymers.

[78]  R. Farías,et al.  Microcin 25, a novel antimicrobial peptide produced by Escherichia coli , 1992, Journal of bacteriology.

[79]  T. Ganz,et al.  Antimicrobial peptides of leukocytes , 1997, Current opinion in hematology.

[80]  J. V. D. van der Meer,et al.  Update on meningococcal disease with emphasis on pathogenesis and clinical management. , 2000, Clinical microbiology reviews.

[81]  C. Walsh,et al.  The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition. , 2001, Journal of molecular biology.

[82]  R. Hancock,et al.  Sublethal Concentrations of Pleurocidin-Derived Antimicrobial Peptides Inhibit Macromolecular Synthesis in Escherichia coli , 2002, Antimicrobial Agents and Chemotherapy.

[83]  J. Lutkenhaus Regulation of cell division in E. coli. , 1990, Trends in genetics : TIG.

[84]  J. Kobayashi,et al.  Cloning of mRNA Sequences for Two Antibacterial Peptides in a Hemipteran Insect, Riptortus clavatus , 1996, Zoological science.

[85]  Shamala Devi Sekaran,et al.  Activity of Novel Synthetic Peptides against Candida albicans , 2015, Scientific Reports.

[86]  Gao Shuang,et al.  Inhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced Inflammation , 2016 .

[87]  Astrid Gräslund,et al.  Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.

[88]  R. Ellis The molecular chaperone concept. , 1990, Seminars in cell biology.

[89]  F. Oppenheim,et al.  Structural Relationship Between Human Salivary Histatins , 1990, Journal of dental research.

[90]  R. Lehrer,et al.  eNAP-2, a novel cysteine-rich bactericidal peptide from equine leukocytes , 1992, Infection and immunity.

[91]  S. Sekaran,et al.  In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin , 2015, Scientific Reports.

[92]  Arwyn Tomos Jones,et al.  Macropinocytosis: searching for an endocytic identity and role in the uptake of cell penetrating peptides , 2007, Journal of cellular and molecular medicine.

[93]  R. M. Pino,et al.  Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis , 2018 .

[94]  Bingyun Li,et al.  Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus , 2012, Antimicrobial Agents and Chemotherapy.

[95]  N. Fukuishi,et al.  Bacterial components regulate the expression of Toll-like receptor 4 on human mast cells , 2007, Inflammation Research.

[96]  Wayne L. Smith,et al.  Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. , 1992, The Journal of biological chemistry.

[97]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[98]  H. Sahl,et al.  Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. , 1981, Journal of general microbiology.

[99]  P. Yu,et al.  Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils. , 2003, Biochemical and biophysical research communications.

[100]  S. Chatterjee,et al.  Indolicidin Targets Duplex DNA: Structural and Mechanistic Insight through a Combination of Spectroscopy and Microscopy , 2014, ChemMedChem.

[101]  A. Bayer,et al.  Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus , 1992, Antimicrobial Agents and Chemotherapy.

[102]  H. Vogel,et al.  Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[103]  Andreas Peschel,et al.  How do bacteria resist human antimicrobial peptides? , 2002, Trends in microbiology.

[104]  H. G. Boman,et al.  Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine , 1993, Infection and immunity.

[105]  Olivier Taboureau,et al.  Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus , 2005, Nature.

[106]  S. Nechaev,et al.  Mutations of Bacterial RNA Polymerase Leading to Resistance to Microcin J25* , 2002, The Journal of Biological Chemistry.

[107]  Ya-li Tang,et al.  The intracellular mechanism of action on Escherichia coli of BF2-A/C, two analogues of the antimicrobial peptide Buforin 2 , 2013, Journal of Microbiology.

[108]  I. C. Almeida,et al.  Ixodidin, a novel antimicrobial peptide from the hemocytes of the cattle tick Boophilus microplus with inhibitory activity against serine proteinases , 2006, Peptides.

[109]  T. Lüders,et al.  Hipposin, a histone-derived antimicrobial peptide in Atlantic halibut (Hippoglossus hippoglossus L.). , 2003, Biochimica et biophysica acta.

[110]  R. Hoffmann,et al.  Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. , 2010, Journal of medicinal chemistry.

[111]  P. Tempst,et al.  Apidaecin multipeptide precursor structure: a putative mechanism for amplification of the insect antibacterial response. , 1993, The EMBO journal.

[112]  O. Kohashi,et al.  Morphology of defensin-treated Staphylococcus aureus , 1995, Infection and immunity.

[113]  V. Mutt,et al.  Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. , 1991, European journal of biochemistry.

[114]  H. Sahl,et al.  Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential , 1996, Infection and immunity.

[115]  M. Ghannoum,et al.  Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro , 1993, Antimicrobial Agents and Chemotherapy.

[116]  J. Nakayama,et al.  Peptide-Lipid Huge Toroidal Pore, a New Antimicrobial Mechanism Mediated by a Lactococcal Bacteriocin, Lacticin Q , 2009, Antimicrobial Agents and Chemotherapy.

[117]  H. Tani,et al.  Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis. , 1991, Biochemical and biophysical research communications.

[118]  P. Koski,et al.  Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane , 1988, Infection and immunity.

[119]  A. Bayer,et al.  Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein , 1992, Infection and immunity.

[120]  T. Ganz,et al.  Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae , 2004, BMC infectious diseases.

[121]  M. Edgerton,et al.  How Does It Kill?: Understanding the Candidacidal Mechanism of Salivary Histatin 5 , 2014, Eukaryotic Cell.

[122]  Y. Shai,et al.  Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. , 1995, Biochemistry.

[123]  M. Zasloff Innate immunity, antimicrobial peptides, and protection of the oral cavity , 2002, The Lancet.

[124]  R. Hancock,et al.  The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa , 1994, Molecular microbiology.

[125]  G. Diamond,et al.  Isolation and Characterization of Pleurocidin, an Antimicrobial Peptide in the Skin Secretions of Winter Flounder* , 1997, The Journal of Biological Chemistry.

[126]  J. Solbiati,et al.  Genetic analysis of plasmid determinants for microcin J25 production and immunity , 1996, Journal of bacteriology.

[127]  D. Phoenix,et al.  Anionic antimicrobial peptides from eukaryotic organisms. , 2009, Current protein & peptide science.

[128]  M. Benincasa,et al.  Role of the Escherichia coli SbmA in the antimicrobial activity of proline‐rich peptides , 2007, Molecular microbiology.

[129]  R. Kolter,et al.  The DNA replication inhibitor microcin B17 is a forty‐three‐amino‐acid protein containing sixty percent glycine , 1986, Proteins.

[130]  G. Montelione,et al.  Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot. , 2003, Journal of the American Chemical Society.

[131]  M. Björklund,et al.  Streptococcus mutans, Caries and Simulation Models , 2010, Nutrients.

[132]  Shamala Devi Sekaran,et al.  Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae , 2015, PloS one.

[133]  F. S. Hsiao,et al.  The proteome targets of intracellular targeting antimicrobial peptides , 2016, Proteomics.

[134]  L. Yang,et al.  Barrel-stave model or toroidal model? A case study on melittin pores. , 2001, Biophysical journal.

[135]  T. Kaczorowski,et al.  Identification, characterization and purification of the lantibiotic staphylococcin T, a natural gallidermin variant , 1999, Journal of applied microbiology.

[136]  V. Smith,et al.  Purification and characterization of a proline-rich antibacterial peptide, with sequence similarity to bactenecin-7, from the haemocytes of the shore crab, Carcinus maenas. , 1996, European journal of biochemistry.

[137]  Y. Sugiura,et al.  Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action. , 1992, Biochemistry.

[138]  Michael R. Yeaman,et al.  Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.

[139]  R. Hancock,et al.  Structure and Mechanism of Action of an Indolicidin Peptide Derivative with Improved Activity against Gram-positive Bacteria* , 2001, The Journal of Biological Chemistry.

[140]  William Wiley Navarre,et al.  Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope , 1999, Microbiology and Molecular Biology Reviews.

[141]  Yue Sun,et al.  Inhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced Inflammation , 2015, Mediators of inflammation.

[142]  C. Whitfield,et al.  Lipopolysaccharide endotoxins. , 2002, Annual review of biochemistry.

[143]  J. Tam,et al.  Design of Gram-negative selective antimicrobial peptides. , 2001, Biochemistry.

[144]  C. B. Park,et al.  Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. , 2000, Biochemistry.

[145]  H. Erdjument-Bromage,et al.  Biodiversity of apidaecin-type peptide antibiotics. Prospects of manipulating the antibacterial spectrum and combating acquired resistance. , 1994, The Journal of biological chemistry.

[146]  B. Finlay,et al.  Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[147]  H. Sahl,et al.  The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II , 1998, Antimicrobial Agents and Chemotherapy.

[148]  Y. Shai,et al.  Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .

[149]  C. Ross,et al.  Identification of a proline‐arginine‐rich antibacterial peptide from neutrophils that is analogous to PR‐39, an antibacterial peptide from the small intestine , 1994, Journal of leukocyte biology.

[150]  Wei-fen Li,et al.  Apidaecin-type peptides: Biodiversity, structure–function relationships and mode of action , 2006, Peptides.

[151]  M. Selsted,et al.  Purification and in vitro activities of rabbit platelet microbicidal proteins , 1997, Infection and immunity.

[152]  A. Bayer,et al.  In Vitro Antibacterial Activities of Platelet Microbicidal Protein and Neutrophil Defensin against Staphylococcus aureus Are Influenced by Antibiotics Differing in Mechanism of Action , 1999, Antimicrobial Agents and Chemotherapy.

[153]  Elizabeth M. Nolan,et al.  Human defensin 5 disulfide array mutants: disulfide bond deletion attenuates antibacterial activity against Staphylococcus aureus. , 2011, Biochemistry.

[154]  Jennifer L. Knight,et al.  Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. , 2004, Molecular cell.

[155]  H. Sahl,et al.  Insights into In Vivo Activities of Lantibiotics from Gallidermin and Epidermin Mode-of-Action Studies , 2006, Antimicrobial Agents and Chemotherapy.

[156]  C. Hernández-Chico,et al.  The peptide antibiotic microcin B17 induces double‐strand cleavage of DNA mediated by E. coli DNA gyrase. , 1991, The EMBO journal.

[157]  A. Vitiello,et al.  Cutting Edge: Mast Cell Antimicrobial Activity Is Mediated by Expression of Cathelicidin Antimicrobial Peptide 1 , 2003, The Journal of Immunology.

[158]  C. B. Park,et al.  Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[159]  T. Ganz,et al.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. , 1989, The Journal of clinical investigation.

[160]  S. N. Witt,et al.  The insect antimicrobial peptide, l‐pyrrhocoricin, binds to and stimulates the ATPase activity of both wild‐type and lidless DnaK , 2004, FEBS letters.

[161]  H. Sahl,et al.  Human β-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci , 2010, Infection and Immunity.

[162]  Durba Sengupta,et al.  Toroidal pores formed by antimicrobial peptides show significant disorder. , 2008, Biochimica et biophysica acta.

[163]  C. B. Park,et al.  A novel antimicrobial peptide from Bufo bufo gargarizans. , 1996, Biochemical and biophysical research communications.

[164]  C. B. Park,et al.  Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.

[165]  Søren Neve,et al.  Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II , 2010, Science.

[166]  H. Sahl,et al.  The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. , 1997, European journal of biochemistry.

[167]  Elizabeth M. Nolan,et al.  A Bacterial Mutant Library as a Tool to Study the Attack of a Defensin Peptide , 2014, Chembiochem : a European journal of chemical biology.

[168]  J. Bruenn,et al.  Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways , 2000, Antimicrobial Agents and Chemotherapy.

[169]  Chien-Sheng Chen,et al.  Lactoferricin B Inhibits the Phosphorylation of the Two-Component System Response Regulators BasR and CreB* , 2011, Molecular & Cellular Proteomics.

[170]  H. Sahl,et al.  Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. , 2004, The Journal of antimicrobial chemotherapy.

[171]  J. Tagg,et al.  Purification and Characterization of Streptin, a Type A1 Lantibiotic Produced by Streptococcus pyogenes , 2003, Applied and Environmental Microbiology.

[172]  Randall Todd,et al.  Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae — Washoe County, Nevada, 2016 , 2017, MMWR. Morbidity and mortality weekly report.

[173]  F. Hartl,et al.  DnaK functions as a central hub in the E. coli chaperone network. , 2012, Cell reports.

[174]  T. Weiss,et al.  Neutron off-plane scattering of aligned membranes. I. Method Of measurement. , 1998, Biophysical journal.

[175]  K. Brogden Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[176]  Satyajit Mayor,et al.  Pathways of clathrin-independent endocytosis , 2007, Nature Reviews Molecular Cell Biology.

[177]  R. Farías,et al.  The FhuA protein is involved in microcin 25 uptake , 1993, Journal of bacteriology.

[178]  T. Kubo,et al.  Purification and characterization of a diptericin homologue from Sarcophaga peregrina (flesh fly). , 1992, The Biochemical journal.

[179]  R. P. Ross,et al.  Lantibiotics: structure, biosynthesis and mode of action. , 2001, FEMS microbiology reviews.

[180]  P. Christen,et al.  The Proline-rich Antibacterial Peptide Bac7 Binds to and Inhibits in vitro the Molecular Chaperone DnaK , 2009, International Journal of Peptide Research and Therapeutics.

[181]  R. Hancock,et al.  The relationship between peptide structure and antibacterial activity , 2003, Peptides.